retatrutide or tesamorelin Retatrutide and Tesamorelin the Combined

Immunofluorescence analysis demonstrated FOXO4 nuclear accumulation in aortic tissues of D-galactose-induced aging mice (Supplementary Figure S1B)

If additional glycemic control is needed, increase the dose to 1.2 mg daily, and if additional glycemic control is still required, increase to 1.8 mg daily after at least 1 week of treatment with the 1.2 mg daily dose

On top of that, berberine stimulates endogenous GLP-1 secretion from L-cells in the intestinal lining through bitter taste receptor activation

as well as by characteristics of the treatment itself (such as how frequently it needs to be taken, or how tolerable the side-effects are)